减少城市贫民窟青少年抑郁、自杀/自伤风险及其他显著情绪或医学无法解释主诉的污名并改善管理的干预:ARTEMIS项目方案
ARTEMIS项目计划在印度维杰亚瓦达和新德里各30个贫民窟集群开展整群随机对照试验,对10至19岁青少年用PHQ-9筛查抑郁和自杀意念,建立高风险队列(PHQ-9≥10分和/或自杀风险问题≥2分)与等量非高风险队列。干预包括由青少年共同创作的反污名运动和基于移动技术的电子决策支持系统,假设可减少污名、抑郁和自杀风险并改善高风险青少年心理健康。
要点
- 在印度两城市各30个贫民窟集群开展整群随机对照试验,纳入10至19岁青少年。
- 用PHQ-9筛查,高风险定义为评分≥10分和/或自杀风险问题≥2分。
- 干预含青少年共同创作的反污名运动和移动技术电子决策支持系统。
核心结论
- 作者假设:由青少年共同创作的反污名运动联合基于移动技术的电子决策支持系统,将有助于减少污名、抑郁和自杀风险,并改善印度城市贫民窟高风险青少年的心理健康。
研究设计与样本
- 整群随机对照试验,在印度维杰亚瓦达和新德里各30个贫民窟集群实施。
- 纳入10至19岁青少年,使用患者健康问卷(PHQ-9)筛查抑郁和自杀意念。
- 衍生两个评估队列:高风险队列为PHQ-9评分≥10分和/或PHQ-9自杀风险问题评分≥2分者,非高风险队列纳入等量按上述评分不属于高风险者。
临床怎么用
- ARTEMIS将重点提高青少年和贫民窟社区对这些精神健康状况的认识,加强现有基层卫生工作者的技能并促进任务分担。
- 研究结果将为政府提供证据,用于制定策略以填补为城市贫民窟中经历抑郁、其他显著情绪或医学无法解释主诉或自杀风险/自伤增加的青少年提供照护的缺口。
- 原文指出该研究不仅对印度有意义,对其它低收入和中等收入国家也应具有相关性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There are around 250 million adolescents in India. Adolescents are vulnerable to common mental disorders with depression and self-harm accounting for a major share of the burden of death and disability in this age group. Around 20% of children and adolescents are diagnosed with/ or live with a disabling mental illness. A national survey has found that suicide is the third leading cause of death among adolescents in India. The authors hypothesise that an intervention involving an anti-stigma campaign co-created by adolescents themselves, and a mobile technology-based electronic decision support system will help reduce stigma, depression, and suicide risk and improve mental health for high-risk adolescents living in urban slums in India. METHODS: The intervention will be implemented as a cluster randomised control trial in 30 slum clusters in each of the cities of Vijayawada and New Delhi in India. Adolescents aged 10 to 19 years will be screened for depression and suicide ideation using the Patient Health Questionnaire (PHQ-9). Two evaluation cohorts will be derived-a high-risk cohort with an elevated PHQ-9 score ≥ 10 and/or a positive response (score ≥ 2) to the suicide risk question on the PHQ-9, and a non-high-risk cohort comprising an equal number of adolescents not at elevated risk based on these scores. DISCUSSION: The key elements that ARTEMIS will focus on are increasing awareness among adolescents and the slum community on these mental health conditions as well as strengthening the skills of existing primary healthcare workers and promoting task sharing. The findings from this study will provide evidence to governments about strategies with potential for addressing the gaps in providing care for adolescents living in urban slums and experiencing depression, other significant emotional or medically unexplained complaints or increased suicide risk/self-harm and should have relevance not only for India but also for other low- and middle-income countries. TRIAL STATUS: Protocol version - V7, 20 Dec 2021 Recruitment start date: tentatively after 15th July 2022 Recruitment end date: tentatively 14th July 2023 (1 year after the trial start date) TRIAL REGISTRATION: The trial has been registered in the Clinical Trial Registry India, which is included in the WHO list of Registries ( https://www.who.int/clinical-trials-registry-platform/network/primary-registries ) Reference No. CTRI/2022/02/040307 . Registered on 18 February 2022. The tentative start date of participant recruitment for the trial will begin after 15th July 2022.
引用
- Yatirajula SK, Kallakuri S, Paslawar S, et al. An intervention to reduce stigma and improve management of depression, risk of suicide/self-harm and other significant emotional or medically unexplained complaints among adolescents living in urban slums: protocol for the ARTEMIS project. Trials. 2022. PMID: 35906663. doi:10.1186/s13063-022-06539-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。